Design

Fetal Aneuploidies (Trisomy 21, Trisomy 18 and Trisomy 13) Detection CapitalBio
Trisomy 21 (Down syndrome), trisomy 18 (Edward's syndrome), and trisomy 13 (Patau's syndrome) are the three most prevalent autosomal aneuploid diseases. The incidence in newborns is 1/(600-800), 1/(3500-8000), and 1/(7000-20000). Intellectual disability, developmental delay, multiple deformities, reproductive disorders, etc. are common in children.

Using a fetal chromosome aneuploidy (T21, T18, T13) detection kit (semiconductor sequencing), doctors can reliably identify these conditions in unborn children (trisomy 21, trisomy 18, and trisomy 13).
https://www.capitalbiotechnology.com/products/fetal-aneuploidies-trisomy-21-trisomy-18-and-trisomy-13-detection/